BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10435026)

  • 1. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.
    Marie C; Mossiat C; Gros C; Schwartz JC; Lecomte JM; Bralet J
    Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans.
    Laurent S; Boutouyrie P; Azizi M; Marie C; Gros C; Schwartz JC; Lecomte JM; Bralet J
    Hypertension; 2000 May; 35(5):1148-53. PubMed ID: 10818079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute natriuretic effect of fasidotrilat, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in rats with heart failure.
    Marie C; Mossiat C; Lecomte JM; Bralet J
    Pharmacology; 1998 Jun; 56(6):291-6. PubMed ID: 9654215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
    Marie C; Mossiat C; Lecomte JM; Schwartz JC; Bralet J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1324-31. PubMed ID: 8531099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.
    Burrell LM; Farina NK; Balding LC; Johnston CI
    Hypertension; 2000 Dec; 36(6):1105-11. PubMed ID: 11116133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
    Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
    Kelly MP; Kahr O; Aalkjaer C; Cumin F; Samani NJ
    Clin Sci (Lond); 1997 May; 92(5):455-65. PubMed ID: 9176018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
    Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
    Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.
    Wollert KC; Studer R; von Bülow B; Drexler H
    Circulation; 1994 Nov; 90(5):2457-67. PubMed ID: 7955203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on prolonged inhibition of neutral endopeptidase on cardiac hypertrophy in rats with myocardial infarction.
    Marie C; Mossiat C; Gros C; Monteil T; Bralet J
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):593-8. PubMed ID: 8950076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM; Mill JG
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and antihypertrophic effects of omapatrilat in SHR.
    Burrell LM; Droogh J; Man in't Veld O; Rockell MD; Farina NK; Johnston CI
    Am J Hypertens; 2000 Oct; 13(10):1110-6. PubMed ID: 11041166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
    Huang H; Arnal JF; Llorens-Cortes C; Challah M; Alhenc-Gelas F; Corvol P; Michel JB
    Circ Res; 1994 Sep; 75(3):454-61. PubMed ID: 8062419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.